Skip to main content

Market Overview

12 Healthcare Stocks Moving In Thursday's Intraday Session

Share:

Gainers

  • Alphatec Holdings (NASDAQ:ATEC) stock moved upwards by 26.9% to $8.73 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 7.8 million, which is 2172.33% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $553.8 million.
  • CareDx (NASDAQ:CDNA) stock rose 17.07% to $51.35. The current volume of 1.8 million shares is 359.95% of CareDx's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $2.2 billion.
  • Processa Pharmaceuticals (NASDAQ:PCSA) shares increased by 15.85% to $5.1. The current volume of 246.0K shares is 1318.95% of Processa Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:32 EST). The market value of their outstanding shares is at $27.9 million.
  • Exicure (NASDAQ:XCUR) shares rose 15.15% to $1.9. Exicure's stock is trading at a volume of 112.5K shares as of 12:32 EST. This is 63.76% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $165.5 million.
  • Tiziana Life Sciences (NASDAQ:TLSA) stock moved upwards by 13.37% to $5.0. Trading volume for Tiziana Life Sciences's stock is 1.0 million as of 12:32 EST. This is 111.34% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $164.0 million.
  • Cardiff Oncology (NASDAQ:CRDF) shares surged 13.24% to $15.3. Trading volume for Cardiff Oncology's stock is 1.2 million as of 12:32 EST. This is 63.62% of its average full-day volume over the last 100 days. The company's market cap stands at $206.5 million.

 

 

Losers

  • Cytokinetics (NASDAQ:CYTK) shares sank 44.1% to $15.46 during Thursday's regular session. Cytokinetics's stock is trading at a volume of 12.1 million shares as of 12:32 EST. This is 1097.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $919.3 million.
  • Taiwan Liposome Co (NASDAQ:TLC) shares declined by 17.4% to $4.91. As of 12:32 EST, this security is trading at a volume of 225.8K shares, making up 73.16% of its average full-day volume over the last 100 days. The company's market cap stands at $182.9 million.
  • OptimizeRx (NASDAQ:OPRX) shares declined by 15.13% to $18.54. The current volume of 400.5K shares is 264.01% of OptimizeRx's average full-day volume over the last 100 days (last updated at 12:32 EST). The company's market cap stands at $271.4 million.
  • Imara (NASDAQ:IMRA) stock declined by 9.14% to $19.5. As of 12:32 EST, Imara's stock is trading at a volume of 89.1K, which is 146.29% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $336.9 million.
  • AlloVir (NASDAQ:ALVR) shares sank 8.89% to $28.11. As of 12:32 EST, this security is trading at a volume of 65.7K shares, making up 14.46% of its average full-day volume over the last 100 days.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares fell 8.75% to $7.41. As of 12:32 EST, Aridis Pharmaceuticals's stock is trading at a volume of 991, which is 8.82% of its average full-day volume over the last 100 days. The company's market cap stands at $66.1 million.
 

Related Articles (ALVR + ARDS)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks intraday moversIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com